Novartis Aktie
103,50
EUR
-0,70
EUR
-0,67
%
97,78
CHF
+0,26
CHF
+0,27
%
Werbung
Novartis Aktie Analyse
26.10.22 | Novartis Underperform | Credit Suisse Group | |
26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
26.10.22 | Novartis Underweight | Barclays Capital | |
25.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
25.10.22 | Novartis Sell | Deutsche Bank AG | |
25.10.22 | Novartis Neutral | UBS AG | |
25.10.22 | Novartis Buy | Jefferies & Company Inc. | |
24.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
|
|||
14.10.22 | Novartis Underweight | Barclays Capital | |
07.10.22 | Novartis Sell | Deutsche Bank AG | |
05.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
26.09.22 | Novartis Neutral | UBS AG | |
23.09.22 | Novartis Sell | Deutsche Bank AG | |
23.09.22 | Novartis Underweight | Barclays Capital | |
23.09.22 | Novartis Underperform | Credit Suisse Group | |
23.09.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
21.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
21.09.22 | Novartis Sell | Deutsche Bank AG | |
16.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
15.09.22 | Novartis Underperform | Credit Suisse Group | |
14.09.22 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
26.08.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
25.08.22 | Novartis Neutral | UBS AG | |
25.08.22 | Novartis Underweight | JP Morgan Chase & Co. | |
21.07.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
20.07.22 | Novartis Neutral | Credit Suisse Group | |
20.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
20.07.22 | Novartis Sell | Deutsche Bank AG | |
19.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
19.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
19.07.22 | Novartis Neutral | UBS AG | |
19.07.22 | Novartis Buy | Jefferies & Company Inc. | |
18.07.22 | Novartis Underweight | Barclays Capital | |
15.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
13.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
01.07.22 | Novartis Neutral | UBS AG | |
30.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
29.06.22 | Novartis Sell | Deutsche Bank AG | |
22.06.22 | Novartis Neutral | UBS AG | |
22.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
22.06.22 | Novartis Sell | Deutsche Bank AG | |
27.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
28.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
27.04.22 | Novartis Neutral | Credit Suisse Group | |
27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
27.04.22 | Novartis Neutral | UBS AG | |
27.04.22 | Novartis Sell | Deutsche Bank AG |
Werbung
Werbung